Amneal Gets ANDA Approval From FDA for Generic TobraDex

 Shares of Amneal Pharmaceuticals Inc. are trading higher in Monday's after-hours market, following news the company received an abbreviated new drug application approval from the U.S. Food and Drug Administration for the generic version of TobraDex.

TobraDex is used to treat infections and inflammation of the eye.

At 4:40 p.m. ET, shares of Amneal Pharmaceuticals were trading 7.41% higher at $4.64. Volume at the time topped 16,000 shares.

https://www.marketscreener.com/quote/stock/AMNEAL-PHARMACEUTICALS-I-43306881/news/Amneal-Gets-ANDA-Approval-From-FDA-for-Generic-TobraDex-Shares-Higher-35893655/